Masayoshi Iwamoto

Dr. Masayoshi Iwamoto

surgery, Kindai University Hospital, Ōsaka, Japan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MIMasayoshi Iwamoto
Masayoshi Iwamoto
KUKazuki Ueda
Kazuki Ueda
JKJunichiro Kawamura
Junichiro Kawamura
Anastomotic leakage is one of the most dreaded complications of colorectal surgery and is strongly associated with tissue perfusion. Indocyanine green fluorescence angiography (ICG-FA) using indocyanine green and near-infrared systems is an innovative technique that allows the visualization of anastomotic perfusion. Based on this information on tissue perfusion status, surgeons will be able to clearly identify colorectal segments with good blood flow for safer colorectal anastomosis. The results of several clinical trials indicate that ICG-FA may reduce the risk of AL in colorectal resection; however, the level of evidence is not high, as several other studies have failed to demonstrate a reduction in the risk of AL. Several large-scale RCTs are currently underway, and their results will determine whether ICG-FA is, indeed, useful. The major limitation of the current ICG-FA evaluation method, however, is that it is subjective and based on visual assessment by the surgeon. To complement this, the utility of objective evaluation methods for fluorescence using quantitative parameters is being investigated. Promising results have been reported from several clinical trials, but all trials are preliminary owing to their small sample size and lack of standardized protocols for quantitative evaluation. Therefore, appropriately standardized, high-quality, large-scale studies are warranted.

31 July 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MIMasayoshi Iwamoto
Masayoshi Iwamoto
KUKazuki Ueda
Kazuki Ueda
JKJunichiro Kawamura
Junichiro Kawamura
Locally advanced rectal cancer (LARC) remains a major clinical challenge due to its high risk of local recurrence and distant metastasis. Although total mesorectal excision (TME) has been established as the gold standard surgical approach, high recurrence rates associated with surgery alone have driven the development of multimodal preoperative strategies, such as radiotherapy and chemoradiotherapy. More recently, total neoadjuvant therapy (TNT)—which integrates systemic chemotherapy and radiotherapy prior to surgery—and non-operative management (NOM) for patients who achieve a clinical complete response (cCR) have further expanded treatment options. These advances aim not only to improve oncologic outcomes but also to enhance quality of life (QOL) by reducing long-term morbidity and preserving organ function. However, several unresolved issues persist, including the optimal sequencing of therapies, precise risk stratification, accurate evaluation of treatment response, and effective surveillance protocols for NOM. The advent of molecular biomarkers, next-generation sequencing, and artificial intelligence (AI) presents new opportunities for individualized treatment and more accurate prognostication. This narrative review provides a comprehensive overview of the current status of preoperative treatment for LARC, critically examines emerging strategies and their supporting evidence, and discusses future directions to optimize both oncological and patient-centered outcomes. By integrating clinical, molecular, and technological advances, the management of rectal cancer is moving toward truly personalized medicine.

16 January 2023 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
MIMasayoshi Iwamoto
Masayoshi Iwamoto
YMYusuke Makutani
Yusuke Makutani
YYYoshinori Yane
Yoshinori Yane
HUHokuto Ushijima
Hokuto Ushijima
YYYasumasa Yoshioka
Yasumasa Yoshioka
JKJunichiro Kawamura
Junichiro Kawamura

10 July 2025 in Mini-invasive Surgery
Verified
Journal Article
Open access
PDF file
KUKazuki Ueda
Kazuki Ueda
MIMasayoshi Iwamoto
Masayoshi Iwamoto
YYYoshinori Yane
Yoshinori Yane
YMYusuke Makutani
Yusuke Makutani
YYYasumasa Yoshioka
Yasumasa Yoshioka
JKJunichiro Kawamura
Junichiro Kawamura
Robot-assisted rectal resection has increasingly gained acceptance as a minimally invasive surgical approach for rectal cancer, primarily due to its enhanced precision, dexterity, and superior visualization compared to traditional laparoscopic surgery. Accumulating evidence from randomized controlled trials, systematic reviews, and large-scale national registry analyses underscores its feasibility and safety, particularly in technically demanding scenarios such as male patients, obese individuals, and those with low rectal tumors. Robotic surgery demonstrates favorable short-term outcomes, including significantly lower conversion rates, reduced intraoperative blood loss, and accelerated postoperative recovery. Nonetheless, results regarding operative duration, postoperative complications, and cost-effectiveness remain heterogeneous. Additionally, robotic techniques may facilitate improved functional preservation, especially concerning urinary and sexual functions, attributed to superior visualization and precise nerve-sparing capabilities; however, these benefits require further rigorous validation. Continued advancements in robotic technology and growing surgical proficiency necessitate future large-scale, multicenter trials to definitively establish the long-term oncological and functional advantages. Emerging robotic platforms and technological innovations hold promise for reducing costs and enhancing accessibility. This narrative review critically examines current evidence, outlining the clinical benefits, inherent limitations, and prospective advancements in robotic-assisted surgery for rectal cancer.

13 February 2024 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
MIMasayoshi Iwamoto
Masayoshi Iwamoto
YMYusuke M.D. Makutani
Yusuke M.D. Makutani
HUHokuto M.D. Ushijima
Hokuto M.D. Ushijima
RORyotaro M.D. Ogawa
Ryotaro M.D. Ogawa
YYYasumasa M.D. Yoshioka
Yasumasa M.D. Yoshioka
JKJunichiro M.D. Kawamura
Junichiro M.D. Kawamura
An abstract is unavailable. This article is available as a PDF only.